Hub Catalyst-based medical technology company Xeltis has secured European funding of 15 million euros. Xeltis is pioneering a natural recovery-based approach to replacing heart valves and blood vessels, the company said in a press release about the capital injection. This approach should overcome the limitations of existing artificial solutions. At the [...]
Download Catalyst brochure







